Sponsor Pipeline

Neuren Pharmaceuticals Limited Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
2
Recruiting
2
Phase 3
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-13 NCT07593391
An Open-label Study of NNZ-2591 in Pediatric Participants With Phelan-McDermid Syndrome		 Trial sites expanded: 2 -> 6 locations
Active Trials by Phase
Phase 3
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07281079 A Study of NNZ-2591 in Pediatric Participants With Phelan-McDermid Syndrome Phelan-McDermid Syndrome Recruiting
NCT07593391 An Open-label Study of NNZ-2591 in Pediatric Participants With Phelan-McDermid Syndrome Phelan-McDermid Syndrome Recruiting
Get alerts when Neuren Pharmaceuticals Limited's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free